EANM, ASNC release cardiac amyloidosis guidelines

2017 02 10 15 45 57 410 Heart 400

The European Association of Nuclear Medicine (EANM) and the American Society of Nuclear Cardiology (ASNC) have released a "Cardiac Amyloidosis Practice Points" document.

The goal is to identify the critical components involved in performing technetium-99m (Tc-99m) 3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) or Tc-99m hydroxymethylene diphosphonate (HMDP) imaging to evaluate cardiac transthyretin amyloidosis, according to the organizations. The practice points can be downloaded on the EANM's website.

Page 1 of 138
Next Page